The eurozone has been the brightest star on this year’s economic horizon. The region’s output expanded at a 2.5% pace during the second quarter and has been rising continuously for 48 consecutive months.
Pharmaceutical costs represent about 10% of total U.S. health care expenditures, or about $325 billion each year.